Barry Trachtenberg, MD
NPI 1639331473ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· Houston, TX
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (MD) with Houston Cardiovascular Assoc PA, practicing in Houston, Texas. Their prescriptions cost Medicare Part D more than their services did: $12,328,807 for 6,067 claims, against $758,857 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 15 companies reporting payments in 2025, $42,939 in all, mostly speaking and faculty fees. Lists Houston Methodist Hospital and 4 other hospitals as hospital affiliations.
Overview
| NPI | 1639331473 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jul 1, 2008 |
| Last updated in NPPES | Oct 2, 2024 |
| Certified by provider | Oct 2, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | M7700 | TX |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | M7700 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 662 |
|---|---|
| Services billed | 6,055 across 63 procedure codes |
| Paid by Medicare | $758,857 |
Part D prescriptions in 2024
| Prescriptions (claims) | 6,067 · 14,842 30-day fills |
|---|---|
| Patients | 690 |
| Total drug cost | $12,328,807 |
| Generic share | 74% of claims |
Education and affiliations
| Graduation year | 2005 |
|---|---|
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Cardiovascular Disease (Cardiology) |
| Telehealth | Offers telehealth |
Medical group
- Houston Cardiovascular Assoc PAHouston, TX · 82 clinicians
Hospital affiliations
- Houston Methodist HospitalHouston, TX
- Houston Methodist Sugarland HospitalSugar Land, TX
- Houston Methodist the Woodlands HospitalThe Woodlands, TX
- Houston Methodist West HospitalHouston, TX
- Houston Methodist Willowbrook HospitalHouston, TX
Other facilities
- Home Care of TexasHome health agency · Katy, TX
Industry payments (Open Payments)
- 2025$42,939 · 135 payments from 15 companies
- 2024$99,905 · 164 payments from 19 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14,215 | 24 |
| Bridgebio Pharma, Inc. | $10,719 | 22 |
| Alnylam Pharmaceuticals Inc. | $9,552 | 36 |
| Pfizer Inc. | $7,328 | 11 |
| Abbott Laboratories | $556.76 | 18 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$30,862 · 19 payments
- Consulting Fee$8,859 · 4 payments
- Food and Beverage$3,198 · 111 payments
- Education$20.22 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Houston
- 1487948030
- 1720461023
- 1659188621
- 1275864878
- 1104863745
- 1750797205
- 1942492228
- 1962609693
- 1831501014
- 1669836482
- 1841426194
- 1942572599
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Texas →